<code id='37E5D689CC'></code><style id='37E5D689CC'></style>
    • <acronym id='37E5D689CC'></acronym>
      <center id='37E5D689CC'><center id='37E5D689CC'><tfoot id='37E5D689CC'></tfoot></center><abbr id='37E5D689CC'><dir id='37E5D689CC'><tfoot id='37E5D689CC'></tfoot><noframes id='37E5D689CC'>

    • <optgroup id='37E5D689CC'><strike id='37E5D689CC'><sup id='37E5D689CC'></sup></strike><code id='37E5D689CC'></code></optgroup>
        1. <b id='37E5D689CC'><label id='37E5D689CC'><select id='37E5D689CC'><dt id='37E5D689CC'><span id='37E5D689CC'></span></dt></select></label></b><u id='37E5D689CC'></u>
          <i id='37E5D689CC'><strike id='37E5D689CC'><tt id='37E5D689CC'><pre id='37E5D689CC'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:16426
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          New study raises questions about niacin and heart health
          New study raises questions about niacin and heart health

          MattRourke/APNiacin,orvitaminB3,haslongbeenaU.S.publichealthdarlingtothepointthatitisadded,bylaw,toc

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          My yearlong odyssey to get my son’s ADHD medication covered

          AdobeLastJanuary,Iwenttofillmyson’sADHDprescriptionandwashandedabagwithanunfamiliardrugnameonit.Nomi